|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,400.00 JPY | +7.78% |
|
+19.07% | -10.45% |
| 20/02 | Japan Panel Clears First iPS Cell Therapies for Conditional Sale | MT |
| 19/02 | Japanese government panel endorses Sumitomo Pharma's iPS-derived treatment for Parkinson's | RE |
| Market Cap | 4.46TCr 28Cr 24Cr 23Cr 21Cr 39Cr 2.67TCr 40Cr 266.37Cr 104.36Cr 1.34TCr 105.14Cr 102.85Cr | P/E 2025 |
-103x | P/E 2026 | -56.3x |
|---|---|---|---|---|---|
| Enterprise Value | 4.07TCr 26Cr 22Cr 21Cr 19Cr 36Cr 2.44TCr 36Cr 243.08Cr 95Cr 1.22TCr 96Cr 94Cr | EV / Sales 2025 |
356x | EV / Sales 2026 | 255x |
| Free-Float |
74.12% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +7.78% | ||
| 1 week | +19.07% | ||
| Current month | +20.40% | ||
| 1 month | +12.38% | ||
| 3 months | -14.96% | ||
| 6 months | -37.28% | ||
| Current year | -10.45% |
| 1 week | 4,670 |  | 5,490 |
| 1 month | 4,090 | | 5,490 |
| Current year | 3,610 | | 12,400 |
| 1 year | 3,610 | | 12,400 |
| 3 years | 1,443 | | 12,400 |
| 5 years | 1,287 | | 12,400 |
| 10 years | 1,287 | | 12,400 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 01/06/2020 | |
Yoshiki Sawa
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/08/2021 |
| Investor Relations Contact | 44 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 01/08/2020 | |
Yoshiki Sawa
BRD | Director/Board Member | 71 | 01/08/2021 |
Tadashi Samejima
BRD | Director/Board Member | 66 | 01/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/02/25 | Others | Chief Technology Officer | 24,000 | 0.2989% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.78% | +19.07% | -10.74% | +216.90% | 28Cr | |
| -1.37% | +4.78% | +45.99% | -1.23% | 8.07TCr | |
| +2.55% | +13.07% | +2.40% | +30.48% | 5.12TCr | |
| +0.49% | +2.17% | +22.60% | +177.89% | 4.96TCr | |
| +2.87% | +11.29% | -46.98% | -47.72% | 4.55TCr | |
| -1.56% | -2.19% | +59.29% | -25.50% | 3.06TCr | |
| -0.39% | +0.39% | +52.89% | +83.63% | 2.46TCr | |
| +1.27% | +6.28% | +137.81% | -40.32% | 2.39TCr | |
| -1.80% | +11.10% | +4.71% | +196.74% | 2.16TCr | |
| -5.89% | +34.09% | -0.99% | +792.56% | 1.71TCr | |
| Average | +0.39% | +663.44% | +26.70% | +138.34% | 3.45TCr | |
| Weighted average by Cap. | +0.03% | +274.63% | +26.97% | +76.16% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 18Cr 10.99L 10L 9L 8L 15.31L 10Cr 15.56L 1.05Cr 40.95L 5.25Cr 41.26L 40.36L | 21Cr 13.31L 11.54L 10.8L 10L 18.54L 13Cr 18.85L 1.27Cr 49.61L 6.35Cr 49.98L 48.89L |
| Net income | -64Cr -40.43L -35.04L -32.8L -29.93L -56.33L -39Cr -57.27L -3.85Cr -1.51Cr -19Cr -1.52Cr -1.49Cr | -102.2Cr -64.17L -55.61L -52.06L -47.5L -89.39L -61Cr -90.89L -6.1Cr -2.39Cr -31Cr -2.41Cr -2.36Cr |
| Net Debt | -479.3Cr -3.01Cr -2.61Cr -2.44Cr -2.23Cr -4.19Cr -287.03Cr -4.26Cr -29Cr -11Cr -143.67Cr -11Cr -11Cr | -389.9Cr -2.45Cr -2.12Cr -1.99Cr -1.81Cr -3.41Cr -233.49Cr -3.47Cr -23Cr -9.12Cr -116.87Cr -9.19Cr -8.99Cr |
Employees
51
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | JP¥5,400.00 | +7.78% | 1,56,500 |
| 07/26/07 | JP¥5,010.00 | +2.45% | 70,800 |
| 06/26/06 | JP¥4,890.00 | -1.11% | 69,000 |
| 05/26/05 | JP¥4,945.00 | +4.44% | 1,12,200 |
| 04/26/04 | JP¥4,735.00 | +4.41% | 1,10,500 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 4894 Stock
Select your edition
All financial news and data tailored to specific country editions
